Tevogen Bio Holdings Inc. (ticker: TVGN) is an NASDAQ-listed clinical research company. DredgeCap's structured extraction of TVGN's SEC filings surfaces 11 active risk signals, including 9 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. TVGN reported no tagged revenue in revenue and -$26.28M for the period ending 2025-12-31, with operating cash flow of -$12.33M. Cash and equivalents stood at $0. Total assets of $4.38M are exceeded by total liabilities of $12.62M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
TVGN Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Tevogen Bio Holdings Inc. (TVGN) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.